Latest News

• Advocacy Symposium Led by PCCTC Investigator

  Press Releases by admin August 10, 2018

  

  Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Cancer Advocacy Symposium in Detroit, MI...

  Learn More

• Blood Test Predicts Treatment Response, Survival in Metastatic Di...

  Press Releases by admin June 29, 2018

  

  PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study...

  Learn More

• The PCCTC Is Expanding Its Trial Management Capabilities

  Press Releases by admin June 12, 2018

  

  To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our central management team is now seeking an experienced Research Project C...

  Learn More

• IRONMAN: An International Registry To Improve Outcomes in Men wit...

  Press Releases by UroToday April 18, 2018

  

  PCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative. ...

  Learn More

• PCCTC-Developed Apalutamide Gains FDA Approval

  Press Releases by admin March 9, 2018

  

  On February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation AR antagonist apalutamide (Erleada™, Janssen Biotech, Inc.) for pati...

  Learn More

• PCCTC Muscadine (MPX) Study Finds Activity in Select Genotypes

  Press Releases by admin December 19, 2017

  

  A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) gene as a biomarker shows promising results in the 25% of men with the A...

  Learn More